How to Hire IVD Executives Across Assay Development, Regulatory Strategy and Commercial Growth

Why IVD Executive Hiring Requires a Cross-Functional Approach

IVD products include reagents, instruments, software-enabled systems, and other technologies used to examine human specimens and support clinical decisions. Depending on the product, development may involve molecular diagnostics, immunoassays, clinical chemistry, point-of-care testing, or other diagnostic methods. Each category brings different technical, operational, and commercial considerations.

Senior leaders must understand how decisions in one area affect the rest of the organization. Assay design influences analytical performance and workflow. Instrument design can affect usability, maintenance, and laboratory throughput. Regulatory strategy shapes evidence requirements and market-entry planning. Manufacturing and supply-chain decisions influence product consistency, availability, and margins.

Executive candidates should therefore be evaluated on three interconnected capabilities:

• Scientific and technical judgment: The ability to understand assay performance, development risks, intended use, and evidence requirements.
• Regulatory and operational leadership: The ability to coordinate quality systems, regulatory planning, validation, manufacturing, and launch readiness.
• Commercial and strategic execution: The ability to translate product capabilities into a viable market proposition, customer adoption, and sustainable growth.

The relative importance of each capability depends on the organization’s immediate needs. A company developing a new molecular diagnostic platform may prioritize assay and product-development leadership, while an established manufacturer entering new markets may need stronger commercial strategy and regulatory coordination.

Assessing Assay Development and Scientific Leadership

Assay development is central to many IVD businesses, but scientific credentials alone do not establish executive readiness. Hiring teams must determine whether a candidate has guided technical programs through uncertainty, made evidence-based decisions, and coordinated development with downstream business requirements.

Look beyond research accomplishments

A candidate may have extensive publication experience, deep knowledge of a diagnostic technology, or a strong record of laboratory research. Those accomplishments can be valuable, but executive roles often require additional capabilities: prioritizing programs, allocating resources, building multidisciplinary teams, managing development risks, and deciding when a product is ready to advance.

Interviewers should explore how candidates have managed analytical sensitivity and specificity, precision, reproducibility, interference, sample variability, and other performance characteristics relevant to the intended use. They should also ask how the candidate determined which experiments were necessary, interpreted unexpected results, and handled trade-offs between performance, cost, speed, and workflow requirements.

Useful questions include:

• How did the candidate define the intended use and target customer for a diagnostic product?
• Which assay-development decisions did the candidate personally own?
• How were analytical performance requirements translated into development milestones?
• What happened when initial performance results did not meet expectations?
• How did the candidate coordinate assay scientists, software engineers, instrument teams, quality professionals, and clinical experts?

Strong candidates explain both the scientific reasoning and the leadership process behind their decisions. They can identify what they learned from setbacks, how they changed the development plan, and how they communicated risks to stakeholders.

Evaluate the transition from development to product readiness

Research-stage performance does not automatically translate into a robust product. Assays and diagnostic systems may require further work on reproducibility, reagent stability, instrument compatibility, usability, manufacturing controls, and the conditions under which customers will use the product.

Executives should understand how to connect development milestones with design inputs, verification and validation activities, quality requirements, and production planning. Hiring teams should ask for examples of how candidates prepared a technology for transfer into a controlled, repeatable operating environment.

The objective is not to require every executive to perform specialist laboratory work. It is to establish whether the candidate can lead experts, recognize critical technical dependencies, and make sound decisions about readiness, investment, and risk.

Hiring for Regulatory Strategy and Quality Leadership

Regulatory strategy should influence product planning early rather than becoming a final checkpoint before market entry. Requirements vary by jurisdiction, product classification, intended use, technology, and claims. Executives need enough regulatory understanding to ensure that development plans, evidence generation, quality processes, and commercial timelines remain aligned.

Assess strategic understanding of regulatory pathways

For the United States, IVD regulatory considerations may include product classification, applicable premarket requirements, analytical and clinical performance evidence, labeling, quality-system obligations, and post-market responsibilities. Other markets have their own frameworks and conformity-assessment requirements.

Senior candidates should demonstrate that they understand how regulatory decisions affect the broader business. For example, a proposed change in intended use may alter evidence needs. A new testing platform may require early discussion about an appropriate regulatory pathway. A diagnostic developed alongside a therapeutic product may need coordinated planning to support the intended clinical application.

Ask candidates to describe how they have:

• Aligned product development with regulatory strategy and submission planning.
• Worked with regulatory and quality specialists to address evidence gaps.
• Managed changing requirements or unexpected regulatory feedback.
• Balanced launch timing with appropriate quality and compliance controls.
• Prepared teams for product changes, manufacturing changes, and post-market obligations.

Be cautious of candidates who discuss regulatory affairs only in terms of document submission or approval dates. Effective executives recognize the connection between intended use, product claims, evidence quality, quality management, and commercial positioning.

Test judgment under uncertainty

IVD development rarely follows a perfectly predictable path. Performance data may reveal unexpected limitations, external feedback may require additional work, or the commercial team may request a change that affects the evidence strategy.

Present candidates with a realistic scenario and ask how they would respond. For instance, suppose an assay meets several analytical targets but produces inconsistent results in a relevant sample group. The candidate should explain how they would assess the risk, involve technical and quality experts, evaluate potential causes, and decide whether the program should proceed, change direction, or pause.

Look for structured reasoning, transparent escalation, and respect for specialist expertise. Executive confidence is useful, but it should not replace evidence-based decision-making.

Finding Commercial Leaders Who Understand Diagnostic Markets

Commercial growth in IVD depends on more than product availability. Buyers and users may include hospital laboratories, independent laboratories, reference laboratories, healthcare networks, distributors, and other organizations. Their priorities can differ substantially.

Laboratory customers may focus on workflow efficiency, analytical performance, throughput, service support, integration, and total operating costs. Clinicians may prioritize the relevance and reliability of results for clinical decisions. Procurement teams may emphasize price, contract terms, supply reliability, and standardization across sites.

Executives must understand these differences and turn them into a clear market strategy.

Evaluate market segmentation and positioning

Ask candidates how they have identified target customer segments, assessed competitive alternatives, and translated product capabilities into a compelling value proposition. Strong commercial leaders can explain why a product fits a particular workflow or customer need rather than relying on broad claims about innovation.

They should also understand the difference between technical differentiation and commercial value. A new assay feature may be scientifically interesting without changing customer purchasing decisions. A successful market strategy connects product performance to a meaningful use case, operational benefit, or unmet need.

Interview questions can explore:

• How did the candidate prioritize target markets and customer segments?
• What evidence supported the product’s value proposition?
• How did the candidate incorporate customer feedback into product or launch planning?
• How were sales, marketing, applications support, service, and distribution aligned?
• Which indicators were used to evaluate adoption, retention, revenue quality, and commercial execution?

Assess the ability to build repeatable growth

Commercial success should not depend solely on individual relationships or a few early customers. Executives need to build repeatable processes for lead qualification, product demonstrations, customer onboarding, training, service, and account development.

For instrument-based systems, placement strategy and ongoing reagent or consumable demand may be important. For other diagnostic models, purchasing cycles, reimbursement considerations, laboratory workflow, or channel partnerships may carry greater weight. Candidates should understand the economics of the specific business model rather than applying a generic sales strategy.

Also assess how they partner with technical teams. Commercial leaders should communicate market feedback in a way that informs product priorities without allowing isolated customer requests to derail the roadmap.

Choosing the Right Executive Profile for the Company’s Stage

The best IVD executive depends on the company’s stage, portfolio, operating model, and most urgent challenges. Hiring teams should avoid assuming that one leadership profile will work equally well in every environment.

Early-stage diagnostic company

An early-stage organization may need a leader who can translate scientific potential into a defined product strategy, establish development priorities, and build the processes required for future scale. Resource allocation and the ability to work across functions are particularly important.

Company preparing for commercialization

A business approaching launch may prioritize regulatory coordination, product readiness, manufacturing transfer, customer validation, channel development, and launch planning. Candidates should demonstrate that they can coordinate these activities without treating them as disconnected workstreams.

Established IVD manufacturer

An established company may need executives who can manage a broader portfolio, improve operational performance, enter new markets, develop strategic partnerships, or strengthen commercial execution. Experience with organizational complexity and cross-functional accountability may be more important than direct involvement in early assay research.

Before beginning recruitment, leadership teams should define the role’s primary mandate. They should identify the decisions the executive will own, the functions they will lead, the resources available, and the outcomes expected during the first year.

A Practical Framework for Hiring IVD Executives

1. Define the business objective

Start with the problem the hire must solve. Is the organization struggling to advance assay development, coordinate regulatory planning, prepare for launch, or improve market adoption? A specific mandate makes it easier to distinguish essential capabilities from desirable background.

2. Build a competency-based scorecard

Assess candidates against agreed criteria covering technical judgment, regulatory understanding, operational execution, commercial strategy, people leadership, and decision-making. Weight these criteria according to the role rather than treating every competency as equally important.

3. Use structured interviews and practical scenarios

Ask candidates to discuss comparable programs and explain their individual contributions. Use scenarios involving performance gaps, regulatory uncertainty, launch delays, or customer adoption challenges to evaluate how they prioritize competing demands.

4. Verify the depth of experience

Distinguish between observing a program, contributing to it, and being accountable for its outcome. Reference discussions and detailed examples can help establish the candidate’s actual responsibilities, decision authority, and approach to collaboration.

5. Align authority with accountability

Clarify reporting relationships, budget responsibility, team structure, and decision rights before finalizing the hire. An executive cannot reliably deliver cross-functional outcomes if responsibilities are fragmented or essential resources remain unavailable.

Common Mistakes in IVD Executive Recruitment

• Prioritizing credentials over leadership: Scientific qualifications matter, but they do not automatically demonstrate the ability to lead teams, manage resources, and make business decisions.
• Treating regulatory expertise as a late-stage requirement: Regulatory considerations can influence intended use, evidence planning, product design, and market strategy from the beginning.
• Hiring commercial leaders without technical fluency: Executives need to communicate product value accurately and understand the operational realities behind customer promises.
• Using an unrealistic job specification: Requiring deep expertise across every scientific, regulatory, operational, and commercial discipline may eliminate capable candidates whose strengths match the actual mandate.
• Ignoring organizational stage: A leader suited to an established global manufacturer may not be the best fit for a resource-constrained startup, and vice versa.

These mistakes can be reduced through a clearly defined mandate, consistent evaluation criteria, evidence-based interviews, and realistic expectations about what the incoming executive must accomplish.

Conclusion: Build IVD Leadership Around Product and Business Outcomes

Successful IVD executive recruitment connects scientific capability with regulatory judgment and commercial execution. The right leader understands how assay performance, intended use, quality, manufacturing, customer workflows, and market strategy influence one another.

Organizations should begin by identifying their most important business challenge and selecting candidates whose experience directly addresses it. Structured interviews, clear decision rights, and careful validation of individual contributions can help distinguish technically accomplished professionals from executives ready to lead across the product lifecycle.

Whether a company is advancing a new assay, preparing for commercialization, or expanding an established diagnostic portfolio, the objective is the same: appoint a leader who can turn technical potential into a reliable product strategy and sustainable business performance.

Frequently Asked Questions

What experience should an IVD executive have?

The ideal background depends on the role. Relevant experience may include assay development, analytical performance evaluation, regulatory strategy, quality systems, manufacturing readiness, product launches, customer engagement, and commercial growth. Candidates should also demonstrate cross-functional leadership and sound decision-making.

Why is assay development experience important in IVD leadership?

Assay development establishes important aspects of a diagnostic product’s performance and intended application. Executives need to understand how scientific decisions influence evidence requirements, product readiness, customer value, and downstream commercialization.

How should companies evaluate regulatory strategy experience?

Ask candidates how they have integrated regulatory planning with intended use, development milestones, performance evidence, quality processes, and launch planning. Their answers should show strategic judgment and effective collaboration with regulatory and quality specialists.

What makes a strong commercial leader in diagnostics?

A strong commercial leader understands customer needs, diagnostic workflows, product positioning, sales execution, service requirements, and the business model. They can turn product capabilities into a credible value proposition and establish repeatable processes for customer adoption.

Should an IVD company hire a scientific or commercial executive first?

The decision depends on the company’s current constraint. If assay performance or product development is the primary challenge, technical leadership may be the priority. If the product is ready for market but customer adoption is weak, commercial leadership may be more urgent. Some organizations need a broader executive who can coordinate both areas.

How can employers reduce risk when hiring senior IVD executives?

Define the role’s business objectives, use a competency-based scorecard, conduct structured interviews, verify the candidate’s direct contributions, assess cross-functional leadership, and ensure that the role has clear authority and adequate resources.